Medical consequences of pathogenic CNVs in adults: analysis of the UK Biobank

Karen Crawford, Matthew Bracher‐Smith, David Owen, Kimberley Kendall, Elliott Rees, Antonio F. Pardiñas, Mark Einon, Valentina Escott‐Price, James Walters, Michael O’Donovan,

Journal of Medical Genetics · 2018 · 192 citations · 17 references

DOIFull text

Open access

Abstract

Many of the CNVs have profound effects on medical health and mortality, even in people who have largely escaped early neurodevelopmental outcomes. Forty-six CNV-phenotype associations were significant at a false discovery rate threshold of 0.1, all in the direction of increased risk. Known medical consequences of CNVs were confirmed, but most identified associations are novel. Deletions at 16p11.2 and 16p12.1 had the largest numbers of significantly associated phenotypes (seven each). Diabetes, hypertension, obesity and renal failure were affected by the highest numbers of CNVs. Our work should inform clinicians in planning and managing the medical care of CNV carriers.

References

17